Meizhou People's Hospital — Meizhou, Guangdong

Public research footprint of Meizhou People's Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

EGFR Mutant Advanced Non-small Cell Lung Cancer · HER2-positive Breast Cancer · Advanced Gastric or Gastroesophageal Junction Adenocarcinoma · Acute Ischemic Stroke

Recently updated registry entries

NCT07168161 — BDB-001 Phase III Trial in ANCA-Associated Vasculitis (Recruiting)
NCT05132582 — A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+… (Active Not Recruiting)
NCT05253651 — A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Meizhou People's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.